SCM
ADMA icon

Sterling Capital Management’s ADMA Biologics ADMA Stock Holding History

Sterling Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5K Sell
1,502
-23
-2% -$363 ﹤0.01% 2216
2025
Q4 		$27.8K Buy
1,525
+963
+171% +$16.2K ﹤0.01% 2059
2025
Q3 		$8.24K Buy
562
+2
+0.4% +$34 ﹤0.01% 2594
2025
Q2 		$10.2K Buy
560
+317
+130% +$6.46K ﹤0.01% 2125
2025
Q1 		$4.82K Buy
243
+15
+7% +$259 ﹤0.01% 2184
2024
Q4 		$3.91K Sell
228
-1
-0.4% -$19 ﹤0.01% 2562
2024
Q3 		$4.58K Buy
+229
New +$3.56K ﹤0.01% 1800

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sterling Capital Management's ADMA Position: Q1 2026 in Review

Sterling Capital Management reduced its ADMA Biologics (ADMA) stake by 1.5% in Q1 2026, selling an estimated $363 and leaving 1,502 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

Sterling Capital Management first reported a position in ADMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $27.8K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Sterling Capital Management held 1,502 shares of ADMA Biologics worth $13.5K as of Q1 2026.
  • Sterling Capital Management sold 23 ADMA Biologics shares in Q1 2026, an estimated $363.
  • ADMA Biologics made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2216 holding.
  • Sterling Capital Management first reported a position in ADMA Biologics in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's ADMA Biologics position peaked at $27.8K in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.